Symbol
| COPD1
|
Location
| 14q32.13
|
Name
|
pulmonary disease, chronic obstructive, 1 |
Other name(s)
|
alpha-1-antitrypsin deficiency |
Corresponding gene
|
SERPINA1
|
Other symbol(s)
| COPD, A1ATD
|
Main clinical features
|
emphysema with lung destruction in the third and fourth decade with smoking as an aggravating factor
less frequently liver disease in children (infantile cirrhosis) and adults
disorder associated with reduced SERPINA1 plasma levels, predisposing adults to pulmonary emphysema
excessive mobilization of neutrophils into the lung
increased aortic stiffness suggesting increased risk of cardiovascular disease and evidence of occult musculoskeletal changes (PMID: 21138571 ) |
Genetic determination
| autosomal recessive |
Function/system disorder
| respiratory |
Type
| disease
|
Name
| protease inhibitor (antitrypsin alpha 1)
|
Gene mutation | Chromosome rearrangement | Effect | Comments |
|
---|
various types
|  
|  
| most often by homozygosity for the PiZ allele
| |
Remark(s)
|
. targeted gene correction of SERPINA1 deficiency in induced pluripotent stem cells (IPSCs), (potential of combining human iPSCs with genetic correction to generate clinically relevant cells for autologous cell-based therapies) (PMID: 21993621))
Z mutation encodes a misfolded variant of SERPINA1 that is not secreted effectively and accumulates intracellularly in the endoplasmic reticulum of hepatocytes and other SERPINA1-producing cells (PMID: 21702661)) |